Ayurcann Holdings (CSE: AYUR) this morning announced that it has entered into a new supply and manufacturing arrangement. The arrangement has been entered into with that of Joints Cannabis, a premium CBD health and wellness brand.
The arrangement will see Ayurcann supply the firm with CBD distillate, isolate and THC distillate for their health and wellbeing products. The arrangement follows an effort by Joints to aggressively expand from Ontario into the rest of Canada.
Commenting on the arrangement, Igal Sudman, CEO of Ayurcann, Stated, “We see this as another step in our continued expansion across Canada with this premier brand. The market is currently a patchwork of distributors and manufacturers. With mutually beneficial arrangements, like the one with Joints Cannabis, we can create structures that ensure high-quality products are available for consumers across the country reliably and at a reasonable price point.“
Financial details of the arrangement were not released.
Ayurcann Holdings last traded at $0.17 on the CSE.
FULL DISCLOSURE: Ayurcann Holdings is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Ayurcann Holdings on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
